Ikarian Capital, LLC Sc Pharmaceuticals Inc. Transaction History

Ikarian Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$7.0 - $9.82 $919,471 - $1.29 Million	-131,353 Reduced 87.57%	18,647 $132,000
Q2 2023 Aug 14, 2023	BUY	$8.94 - $11.74 $1.34 Million - $1.76 Million	150,000 New	150,000 $1.53 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.52 $1.81 Million - $2.64 Million	-404,625 Reduced 45.77%	479,383 $3.13 Million
Q2 2022 Aug 12, 2022	SELL	$4.3 - $6.48 $370,187 - $557,863	-86,090 Reduced 8.87%	884,008 $4.26 Million
Q1 2022 May 13, 2022	BUY	$3.9 - $6.11 $268,070 - $419,976	68,736 Added 7.63%	970,098 $5.51 Million
Q3 2021 Nov 15, 2021	SELL	$4.93 - $7.15 $954,753 - $1.38 Million	-193,662 Reduced 17.69%	901,362 $5.99 Million
Q2 2021 Aug 16, 2021	SELL	$5.19 - $7.38 $1.11 Million - $1.58 Million	-213,675 Reduced 16.33%	1,095,024 $6.69 Million
Q1 2021 May 17, 2021	SELL	$5.65 - $7.66 $889,581 - $1.21 Million	-157,448 Reduced 10.74%	1,308,699 $8.7 Million
Q4 2020 Feb 12, 2021	SELL	$5.17 - $9.41 $77,550 - $141,150	-15,000 Reduced 1.01%	1,466,147 $7.76 Million
Q3 2020 Nov 16, 2020	BUY	$7.12 - $8.86 $89,000 - $110,750	12,500 Added 0.85%	1,481,147 $11 Million
Q2 2020 Aug 14, 2020	BUY	$7.01 - $10.96 $2.77 Million - $4.33 Million	395,000 Added 36.79%	1,468,647 $10.8 Million
Q1 2020 May 15, 2020	BUY	$5.4 - $10.45 $5.8 Million - $11.2 Million	1,073,647 New	1,073,647 $7.95 Million

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $92.9M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.